Paper8200548
Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
Dent J and 7 others. Gut, 1994. Cited by 182 papers, by iCite.
Cite this record
ConductScience Library. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Papers, record 8200548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8200548
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Esophagitis, Peptic | Major topic |
| Omeprazole | Major topic |
| Ranitidine | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Double-Blind Method | |
| Esophagoscopy | |
| Esophagus | |
| Female | |
| Humans | |
| Hyperplasia | |
| Male | |
| Middle Aged | |
| Recurrence | |
| Time Factors |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1397748 | Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth. | Digestion | 1992 | https://conductscience.org/library/papers/1397748 | PubMed |
| 2 | 1346769 | Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. | Gut | 1992 | https://conductscience.org/library/papers/1346769 | PubMed |
| 3 | 4185638 | A silver nitrate stain for alpha-2 cells in human pancreatic islets. | Acta Soc Med Ups | 1968 | https://conductscience.org/library/papers/4185638 | PubMed |
| 4 | 6832622 | Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. | Gut | 1983 | https://conductscience.org/library/papers/6832622 | PubMed |
| 5 | 3880557 | Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. | Gastroenterology | 1985 | https://conductscience.org/library/papers/3880557 | PubMed |
| 6 | 3041558 | Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. | Scand J Gastroenterol | 1988 | https://conductscience.org/library/papers/3041558 | PubMed |
| 7 | 1397749 | Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. | Digestion | 1992 | https://conductscience.org/library/papers/1397749 | PubMed |
| 8 | 3044912 | Healing and relapse of severe peptic esophagitis after treatment with omeprazole. | Gastroenterology | 1988 | https://conductscience.org/library/papers/3044912 | PubMed |
| 9 | 3072229 | Histopathological classification of nonantral gastric endocrine growths in man. | Digestion | 1988 | https://conductscience.org/library/papers/3072229 | PubMed |
| 10 | 2350532 | Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2350532 | PubMed |
| 11 | 2093018 | Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. | Digestion | 1990 | https://conductscience.org/library/papers/2093018 | PubMed |
| 12 | 1853146 | Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. | Scand J Gastroenterol | 1991 | https://conductscience.org/library/papers/1853146 | PubMed |
| 13 | 1727744 | Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. | Gastroenterology | 1992 | https://conductscience.org/library/papers/1727744 | PubMed |
| 14 | 1759136 | Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease. | Scand J Gastroenterol Suppl | 1991 | https://conductscience.org/library/papers/1759136 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37876257 | [Diagnosis and Treatment of GastroEsophageal Reflux Disease at the Primary Health Care Clinics in Korea]. | Korean J Gastroenterol | 2023 | https://conductscience.org/library/papers/37876257 | PubMed |
| 35683583 | Comparison in Adherence to Treatment between Patients with Mild-Moderate and Severe Reflux Esophagitis: A Prospective Study. | J Clin Med | 2022 | https://conductscience.org/library/papers/35683583 | PubMed |
| 30919071 | Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease. | J Gastroenterol | 2019 | https://conductscience.org/library/papers/30919071 | PubMed |
| 30854351 | Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease. | Can J Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30854351 | PubMed |
| 28301676 | Deprescribing versus continuation of chronic proton pump inhibitor use in adults. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28301676 | PubMed |
| 25464111 | Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/25464111 | PubMed |
| 23667753 | A randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux disease. | J Neurogastroenterol Motil | 2013 | https://conductscience.org/library/papers/23667753 | PubMed |
| 19450297 | GORD in adults. | BMJ Clin Evid | 2008 | https://conductscience.org/library/papers/19450297 | PubMed |
| 18370513 | Meta-Analyses of Cisapride, Omeprazole and Ranitidine in the Treatment of GORD: Implications for Treating Patient Subgroups. | Clin Drug Investig | 1998 | https://conductscience.org/library/papers/18370513 | PubMed |
| 17431508 | Endoscopic treatment for gastroesophageal reflux disease: should you learn the techniques? | Can J Gastroenterol | 2007 | https://conductscience.org/library/papers/17431508 | PubMed |
| 17410461 | Acid-suppressive effects of various regimens of omeprazole in Helicobacter pylori-negative CYP2C19 homozygous extensive metabolizers: which regimen has the strongest effect? | Dig Dis Sci | 2007 | https://conductscience.org/library/papers/17410461 | PubMed |
| 16402242 | Pharmacokinetics of three proton pump inhibitors in Chinese subjects in relation to the CYP2C19 genotype. | Eur J Clin Pharmacol | 2006 | https://conductscience.org/library/papers/16402242 | PubMed |
| 15700122 | [Reflux esophagitis]. | Internist (Berl) | 2005 | https://conductscience.org/library/papers/15700122 | PubMed |
| 15082617 | A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. | Gut | 2004 | https://conductscience.org/library/papers/15082617 | PubMed |
| 14560364 | Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma. | World J Surg | 2003 | https://conductscience.org/library/papers/14560364 | PubMed |
| 12170024 | Medical or surgical therapy for erosive reflux esophagitis: cost-utility analysis using a Markov model. | Ann Surg | 2002 | https://conductscience.org/library/papers/12170024 | PubMed |
| 12141885 | On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations. | Pharmacoeconomics | 2002 | https://conductscience.org/library/papers/12141885 | PubMed |
| 12010078 | Lansoprazole for maintenance of remission of erosive oesophagitis. | Drugs | 2002 | https://conductscience.org/library/papers/12010078 | PubMed |
| 11723599 | Gastroesophageal reflux in infants and children. When to reassure and when to go further. | Can Fam Physician | 2001 | https://conductscience.org/library/papers/11723599 | PubMed |
| 11559645 | Reducing community dyspepsia drug costs: a controlled trial. | Gut | 2001 | https://conductscience.org/library/papers/11559645 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GAST | 2520 | PubTator's text mining | https://conductscience.org/library/genes/2520 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8200548
GET https://conductscience.org/api/papers/v1/8200548/cited_by?page=2